Cargando…

Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis

BACKGROUND: Development of safe and effective chemopreventive agents is a winning strategy in reducing the morbidity and mortality of breast cancer. The current study was to investigate the mechanism-based chemopreventive potential of a Chinese herb formula Yanghe Huayan (YHHY) Decoction on the clas...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingwei, Liu, Xiaofei, Chen, Hongzhi, Sun, Ziyuan, Chen, Hanhan, Wang, Lei, Sun, Xiaohui, Li, Xiangqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373088/
https://www.ncbi.nlm.nih.gov/pubmed/30760265
http://dx.doi.org/10.1186/s12906-019-2456-1
_version_ 1783394901490139136
author Li, Jingwei
Liu, Xiaofei
Chen, Hongzhi
Sun, Ziyuan
Chen, Hanhan
Wang, Lei
Sun, Xiaohui
Li, Xiangqi
author_facet Li, Jingwei
Liu, Xiaofei
Chen, Hongzhi
Sun, Ziyuan
Chen, Hanhan
Wang, Lei
Sun, Xiaohui
Li, Xiangqi
author_sort Li, Jingwei
collection PubMed
description BACKGROUND: Development of safe and effective chemopreventive agents is a winning strategy in reducing the morbidity and mortality of breast cancer. The current study was to investigate the mechanism-based chemopreventive potential of a Chinese herb formula Yanghe Huayan (YHHY) Decoction on the classical 7,12-dimethylbenz(a)anthracene (DMBA) induced rat mammary carcinogenesis model. METHODS: Female Sprague-Dawley rats at 42 days of age were orally administered with a human equivalent dose of YHHY Decoction at 0.02 ml/g (10 mg/ml) once daily, starting 1 wk. before and 4 wks following DMBA treatment. Mammary tumor occurrence was monitored every day. The length of time before palpable tumor is examined is defined as tumor-free survival time. High performance liquid chromatography (HPLC) analyses were adopted to identify major chemical compositions of the decoction. Following bioinformatics data mining and experimental analyses were performed to demonstrate the underlying mechanism of action. RESULTS: DMBA animals receiving YHHY Decoction exhibited a significant delay (P = 0.014) and in some animals prevention (P = 0.046) of tumor occurrence without obvious toxicity. Oncogenic myc activation was significantly suppressed in the DMBA-induced rats by the YHHY treatment. Eight major chemical compositions of the decoction were identified and were shown to interfere with multiple tumorigenic pathways simultaneously in the mammary tumors, including inducing tumor apoptosis and up-regulating pro-apoptotic protein Bax and down-regulating anti-apoptotic protein Bcl-2; suppressing abnormal cell proliferation and the MAPK/ERK, PI3K/AKT signalings; blocking neo-angiogenesis and the VEGF/KDR signaling, and inhibiting oxidative stress in the mammary tumors. CONCLUSION: The multi-components and multi-targeting properties of the YHHY Decoction support its use as a potent chemopreventive drug in breast cancer.
format Online
Article
Text
id pubmed-6373088
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63730882019-02-25 Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis Li, Jingwei Liu, Xiaofei Chen, Hongzhi Sun, Ziyuan Chen, Hanhan Wang, Lei Sun, Xiaohui Li, Xiangqi BMC Complement Altern Med Research Article BACKGROUND: Development of safe and effective chemopreventive agents is a winning strategy in reducing the morbidity and mortality of breast cancer. The current study was to investigate the mechanism-based chemopreventive potential of a Chinese herb formula Yanghe Huayan (YHHY) Decoction on the classical 7,12-dimethylbenz(a)anthracene (DMBA) induced rat mammary carcinogenesis model. METHODS: Female Sprague-Dawley rats at 42 days of age were orally administered with a human equivalent dose of YHHY Decoction at 0.02 ml/g (10 mg/ml) once daily, starting 1 wk. before and 4 wks following DMBA treatment. Mammary tumor occurrence was monitored every day. The length of time before palpable tumor is examined is defined as tumor-free survival time. High performance liquid chromatography (HPLC) analyses were adopted to identify major chemical compositions of the decoction. Following bioinformatics data mining and experimental analyses were performed to demonstrate the underlying mechanism of action. RESULTS: DMBA animals receiving YHHY Decoction exhibited a significant delay (P = 0.014) and in some animals prevention (P = 0.046) of tumor occurrence without obvious toxicity. Oncogenic myc activation was significantly suppressed in the DMBA-induced rats by the YHHY treatment. Eight major chemical compositions of the decoction were identified and were shown to interfere with multiple tumorigenic pathways simultaneously in the mammary tumors, including inducing tumor apoptosis and up-regulating pro-apoptotic protein Bax and down-regulating anti-apoptotic protein Bcl-2; suppressing abnormal cell proliferation and the MAPK/ERK, PI3K/AKT signalings; blocking neo-angiogenesis and the VEGF/KDR signaling, and inhibiting oxidative stress in the mammary tumors. CONCLUSION: The multi-components and multi-targeting properties of the YHHY Decoction support its use as a potent chemopreventive drug in breast cancer. BioMed Central 2019-02-13 /pmc/articles/PMC6373088/ /pubmed/30760265 http://dx.doi.org/10.1186/s12906-019-2456-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Jingwei
Liu, Xiaofei
Chen, Hongzhi
Sun, Ziyuan
Chen, Hanhan
Wang, Lei
Sun, Xiaohui
Li, Xiangqi
Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
title Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
title_full Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
title_fullStr Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
title_full_unstemmed Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
title_short Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis
title_sort multi-targeting chemoprevention of chinese herb formula yanghe huayan decoction on experimentally induced mammary tumorigenesis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373088/
https://www.ncbi.nlm.nih.gov/pubmed/30760265
http://dx.doi.org/10.1186/s12906-019-2456-1
work_keys_str_mv AT lijingwei multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT liuxiaofei multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT chenhongzhi multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT sunziyuan multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT chenhanhan multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT wanglei multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT sunxiaohui multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis
AT lixiangqi multitargetingchemopreventionofchineseherbformulayanghehuayandecoctiononexperimentallyinducedmammarytumorigenesis